B A L Injection

Introduction

B A L is a medication that contains the active ingredient Dimercaprol. It is available under the brand name B A L. This medication is primarily used in the treatment of heavy metal poisoning.

Uses

B A L is prescribed for the treatment of severe cases of heavy metal poisoning, such as arsenic, gold, or mercury poisoning. It works by binding to the heavy metals and facilitating their elimination from the body.

Dosage and Administration

B A L is administered by a healthcare professional in a hospital or clinic setting. The dosage and administration of this medication will be determined by the healthcare provider based on the severity of the poisoning and the patient’s individual needs. Follow the healthcare provider’s instructions regarding the dosage and administration of B A L.

Mechanism of Action

Dimercaprol, the active ingredient in B A L, works by forming complexes with heavy metals in the body. These complexes are then excreted through urine, helping to remove the toxic heavy metals from the system. By binding to heavy metals, Dimercaprol prevents them from causing further harm to the body’s organs and tissues.

Side Effects

Common side effects may include pain or irritation at the injection site, headache, nausea, vomiting, and dizziness. These side effects are usually mild and go away on their own. However, if they persist or become bothersome, inform your healthcare provider.

Serious side effects of B A L are rare but may include allergic reactions, such as difficulty breathing, swelling of the face, lips, tongue, or throat, and rash. If you experience any of these serious side effects, seek immediate medical attention.

Drug Interactions

inform your healthcare provider about all the medications you are currently taking, including prescription, over-the-counter medications, and herbal supplements. B A L may interact with certain medications, including anticoagulants (blood thinners) and medications that affect kidney function. These interactions can potentially increase the risk of side effects or alter the effectiveness of B A L. Your healthcare provider will consider these potential interactions when prescribing B A L.

Precautions

Before using B A L, inform your healthcare provider if you have any allergies, especially to Dimercaprol or any other medications. Additionally, inform your healthcare provider about any other medical conditions you have, including kidney or liver problems.

B A L is contraindicated in individuals with a known hypersensitivity to Dimercaprol or any of its components. Avoid using B A L during pregnancy or while breastfeeding, unless specifically prescribed by your healthcare provider.

Storage

Patient Tips

• Follow all instructions provided by your healthcare provider regarding the use of B A L.
• Inform your healthcare provider about any medications you are currently taking, including over-the-counter medications and herbal supplements.
• If you experience any side effects or have concerns while using B A L, contact your healthcare provider for further guidance.
• Store B A L properly, away from moisture and heat, and out of the reach of children and pets.
• Do not use B A L if the packaging is damaged or if it has expired.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Dimercaprol (Drugs.com) [Accessed 10 Jun. 2024] (online) Available at:
• LiverTox: Clinical and Research Information on Drug-Induced Liver Injury (National Library of Medicine) (National Institute of Diabetes and Digestive and Kidney Diseases) [Accessed 24 Jun. 2024] (online) Available at:
• Mückter H, Liebl B, Reichl FX, Hunder G, Walther U, Fichtl B. Are we ready to replace dimercaprol (BAL) as an arsenic antidote? Hum Exp Toxicol. 1997 Aug;16(8):460-5. doi: 10.1177/096032719701600807. [Accessed 30 Jun. 2024] Available at:
• KAHN JB Jr. Effects of dimercaprol on the metabolism of pentobarbital in mice. J Pharmacol Exp Ther. 1953 Nov;109(3):292-300. [Accessed 22 Jun. 2024] Available at: